SUSQUEHANNA INTERNATIONAL GROUP, LLP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$75,855,951
-45.3%
519,419
-13.5%
0.02%
-48.3%
Q2 2023$138,784,338
+18.8%
600,798
+24.6%
0.03%
+16.0%
Q1 2023$116,831,823
-36.7%
482,258
-24.2%
0.02%
-46.8%
Q4 2022$184,559,526
+3315.2%
635,864
+664.8%
0.05%
+4600.0%
Q3 2022$5,404,000
+3.1%
83,137
+13.6%
0.00%0.0%
Q2 2022$5,239,000
-28.0%
73,200
-1.3%
0.00%0.0%
Q1 2022$7,275,000
-58.8%
74,150
-64.4%
0.00%
Q4 2021$17,674,000
+134.3%
208,562
+120.6%
0.00%
-100.0%
Q3 2021$7,543,000
+79.8%
94,536
+119.5%
0.00%
Q2 2021$4,196,000
+4.0%
43,070
+24.9%
0.00%
Q1 2021$4,035,000
-60.2%
34,494
-62.2%
0.00%
-100.0%
Q4 2020$10,134,000
-31.5%
91,140
-26.9%
0.00%
-66.7%
Q3 2020$14,797,000
+1.8%
124,626
-2.9%
0.00%0.0%
Q2 2020$14,531,000
+16.4%
128,311
-31.4%
0.00%
-25.0%
Q1 2020$12,487,000
-23.7%
187,035
+4.1%
0.00%
-20.0%
Q4 2019$16,367,000
+156.7%
179,637
+142.9%
0.01%
+400.0%
Q3 2019$6,377,000
-87.1%
73,960
-84.3%
0.00%
-83.3%
Q2 2019$49,374,000
+41.3%
471,078
+68.9%
0.01%
-57.1%
Q1 2019$34,934,000
+37.3%
278,883
+23.6%
0.01%
+40.0%
Q4 2018$25,438,000
-49.0%
225,675
-3.1%
0.01%
-41.2%
Q3 2018$49,871,000
+16.0%
232,900
+51.5%
0.02%
+13.3%
Q2 2018$42,989,000
+23650.8%
153,700
+1211.0%
0.02%
Q1 2017$181,00011,7240.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders